MDPI and ACS Style
Venugopala, K.N.; Al-Shar’i, N.A.; Dahabiyeh, L.A.; Hourani, W.; Deb, P.K.; Pillay, M.; Abu-Irmaileh, B.; Bustanji, Y.; Chandrashekharappa, S.; Tratrat, C.;
et al. Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives. Antibiotics 2022, 11, 831.
https://doi.org/10.3390/antibiotics11070831
AMA Style
Venugopala KN, Al-Shar’i NA, Dahabiyeh LA, Hourani W, Deb PK, Pillay M, Abu-Irmaileh B, Bustanji Y, Chandrashekharappa S, Tratrat C,
et al. Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives. Antibiotics. 2022; 11(7):831.
https://doi.org/10.3390/antibiotics11070831
Chicago/Turabian Style
Venugopala, Katharigatta N., Nizar A. Al-Shar’i, Lina A. Dahabiyeh, Wafa Hourani, Pran Kishore Deb, Melendhran Pillay, Bashaer Abu-Irmaileh, Yasser Bustanji, Sandeep Chandrashekharappa, Christophe Tratrat,
and et al. 2022. "Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives" Antibiotics 11, no. 7: 831.
https://doi.org/10.3390/antibiotics11070831